- Home
- MET vs BDX Comparison
MET vs BDX Comparison
Compare MET & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MET | BDX |
|---|---|---|
| Founded | 1863 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.1B | 51.5B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | MET | BDX |
|---|---|---|
| Price | $68.03 | $159.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $95.00 | ★ $189.60 |
| AVG Volume (30 Days) | ★ 3.6M | 2.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.30% | 2.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $4.48 | $2.53 |
| P/E Ratio | ★ $16.82 | $118.97 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $65.21 | $158.20 |
| 52 Week High | $83.85 | $231.82 |
Technical Indicators
Market Signals| Indicator | MET | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 28.35 | 23.13 |
| Support Level | N/A | N/A |
| Resistance Level | $81.13 | $195.22 |
| Average True Range (ATR) | 2.07 | 4.18 |
| MACD | -0.57 | -1.05 |
| Stochastic Oscillator | 0.16 | 3.91 |
Price Performance
Historical ComparisonAbout MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
About BDX Becton Dickinson and Company
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.